KAPLAN GILLA 4
4 · Tyra Biosciences, Inc. · Filed Jun 18, 2024
Insider Transaction Report
Form 4
KAPLAN GILLA
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-06-13−61,392→ 0 totalExercise: $0.61Exp: 2030-01-26→ Common Stock (61,392 underlying) - Exercise/Conversion
Common Stock
2024-06-13$0.61/sh+61,392$37,449→ 89,623 total
Footnotes (1)
- [F1]Fully vested.